The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
A review of 5 clinical trials with 4199 total participants found that, despite lowering blood pressure, the lowest dose (5 mg/week) of Tirzepatide increased HR by 1-4 bpm, interesting to see my microdose at 0.5 mg/week showing similar side effects.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
A review of 5 clinical trials with 4199 total participants found that, despite lowering blood pressure, the lowest dose (5 mg/week) of Tirzepatide increased HR by 1-4 bpm, interesting to see my microdose at 0.5 mg/week showing similar side effects.
interesting to see my microdose at 0.5 mg/week showing similar side effects.